Angewandte
Chemie
Bioconjugation
Development and Optimization of Glaser–Hay Bioconjugations**
Jessica S. Lampkowski, Jordan K. Villa, Travis S. Young, and Douglas D. Young*
Abstract: The prevalence of bioconjugates in the biomedical
sciences necessitates the development of novel mechanisms to
facilitate their preparation. Towards this end, the translation of
the Glaser–Hay coupling to an aqueous environment is
examined, and its potential as a bioorthogonal conjugation
reaction is demonstrated. This optimized, novel, and aqueous
Glaser–Hay reaction is applied towards the development of
bioconjugates utilizing protein expressed with an alkynyl
unnatural amino acid. Unnatural amino acid technology
provides a degree of bioorthognality and specificity not feasible
with other methods. Moreover, the scope of the reaction is
demonstrated through protein–small molecule couplings,
small-molecule–solid-support couplings, and protein–solid-
support immobilizations.
bioconjugation strategies are necessary to maximize the
utility of bioconjugates.
While bioconjugations dependent on the natural chemical
functionality in proteins have found usefulness, they are often
associated with a lack of control over both the number of
conjugation sites and their location.[9] Thus, the introduction
of bioorthogonal handles to proteins proffers an additional
degree of control over the reaction. One mechanism that is
extremely effective in the introduction of novel functionality
is through site-specific incorporation of unnatural amino acids
(UAAs). Utilizing an evolved aminoacyl-tRNA synthetase
(aaRS)/tRNA cognate pair, a plethora of UAAs have been
introduced site-specifically into proteins in response to
a mutated TAG stop codon within the mRNA.[10] This
method has been employed in numerous applications; how-
ever, it is perhaps most useful in the installation of a bio-
orthogonal handle for bioconjugations.[11] A recent example
includes employing a Sonogashira reaction to couple an
alkyne UAA within a protein to an aryl halide.[5,12]
Specifically, we became interested in applying the Glaser–
Hay coupling of terminal alkynes as a novel biochemical
conjugation strategy (Figure 1A).[13] The Glaser–Hay reac-
tion affords an ideal conjugation strategy as it confers the
formation of a highly stable and rigid carbon–carbon bond,
can be conducted under mild conditions, does not utilize
potentially photosensitive azides, and confers a geometrically
well-defined linear conjugate. Moreover, the reagents/cata-
lysts are cost-efficient, numerous alkyne linkers and con-
jugation partners are commercially available, and the product
is a highly oxidized diyne capable of numerous additional
reactions.
To assess the feasibility of employing a Glaser–Hay
reaction towards bioconjugations, the compatibility of the
reaction to aqueous conditions had to be assessed. To our
knowledge a Glaser–Hay reaction has not previously been
reported in an aqueous solution. Consequently, proof-of-
concept couplings were conducted based on previously
optimized Glaser–Hay conditions in organic solvents involv-
ing the homodimerizaton of either phenylacylene or prop-
argyl alcohol. Gratifyingly, the reaction proceeds to comple-
tion in an aqueous solvent after 16 h at room temperature
with CuI/tetramethylethylenediamine (TMEDA) in greater
than 95% yields.
B
ioconjugates have found a wide degree of relevance as
both diagnostics and therapeutics, along with functional
materials.[1,2] Consequently, the development of novel meth-
ods for their preparation has far-reaching applications.
Various protein bioconjugation reactions are well-known
and regularly employed, including reactions involving mala-
mides, isocyanates, NHS esters, and iodoacetamides with
nucleophilic amino acid residues.[3] Moreover, novel chemical
functionalities have been introduced to further the technol-
ogy and afford 1,3-dipolar cycloadditions, photo-cross-link-
ing, transition-metal-mediated alkyne couplings, and oxime
formations.[4,5] These reactions all must meet several key
requirements to be useful in the generation of bioconjugates.
These include compatibility with aqueous media, a physiolog-
ically stable interaction between the two coupling partners,
biologically compatible and mild reaction conditions, and
ideally a degree of chemoselectivity.[1,6] Arguably the most
widely utilized bioconjugation reaction is the Husigen cycli-
zation reaction involving an alkyne and azide to yield a highly
stable triazole linker.[7] This reaction has been employed in
the preparation of a wide range of bioconjugates and a range
of variant reactions have been developed in the absence of
catalysts to increase its biocompatibility.[8] Despite the robust
nature of this reaction, further investigations into other
[*] J. S. Lampkowski, J. K. Villa, Dr. D. D. Young
Department of Chemistry, College of William & Mary
P.O. Box 8795, Williamsburg, VA 23187 (USA)
E-mail: dyoung01@wm.edu
To utilize this reaction within the context of a protein, an
alkyne moiety must be introduced into the protein as
a bioconjugation handle. Conveniently an aaRS that recog-
nizes propargyloxyphenylalanine (1) has already been
evolved, and a convenient synthesis of the alkynyl UAA is
known (Figure 1B).[14] Based on the fluorescent properties of
green fluorescent protein (GFP), it is an ideal protein for
optimization of the bioconjugation reaction. As such, a TAG
codon was introduced at residue 151, which has previously
Dr. T. S. Young
California Institute of Biomedical Research
11119 N. Torrey Pines Rd, La Jolla, CA 92037 (USA)
[**] We would like to acknowledge the Jeffress Memorial Trust and the
College of William & Mary for financial support. We would also like
to thank Dr. Peter Schultz at The Scripps Research Institute for the
pEVOL-pPrF plasmid.
Supporting information for this article is available on the WWW
Angew. Chem. Int. Ed. 2015, 54, 9343 –9346
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
9343